|
CN112206307A
|
|
Injectable temperature-sensitive hydrogel and preparation method and application thereof
|
|
CN111840512A
|
|
Composition for treating cartilage repair and/or osteoarthritis
|
|
CN111494392A
|
|
Composition for treating acute lung injury and application thereof
|
|
CN111529526A
|
|
Application of compound in preparation of medicine for treating acute pancreatitis
|
|
CN111514137A
|
|
Application of compound in preparation of medicine for treating acute lung injury
|
|
CN111494602A
|
|
Composition for treating acute pancreatitis and application thereof
|
|
CN111569046A
|
|
Application of polypeptide in preparation of medicine for treating pancreatitis and medicine containing polypeptide
|
|
CN111358935A
|
|
Application of polypeptide in preparing anti-tumor and/or tumor metastasis inhibiting medicine and medicine
|
|
CN111358937A
|
|
Application of FGF-2 derivative polypeptide in preparation of medicine for promoting cartilage repair and/or treating osteoarthritis
|
|
CN111303242A
|
|
KdPT modified peptide
|
|
CN111265652A
|
|
Application of polypeptide in preparing medicine for treating ischemic cerebrovascular disease
|
|
CN111150831A
|
|
Application of polypeptide Kdpt
|
|
CN111320682A
|
|
Application of polypeptide in preparation of medicine for promoting cartilage repair and/or treating osteoarthritis
|
|
CN111346217A
|
|
New application of polypeptide TDL23
|
|
CN111346216A
|
|
Composition for treating cerebral apoplexy and application thereof
|
|
CN111249446A
|
|
New use of polypeptide and its salt
|
|
CN111214649A
|
|
Application of BM23 peptide in preparing medicine for treating ischemic cerebrovascular disease
|
|
CN110950927A
|
|
Peptide GGS11 for promoting cartilage regeneration and application thereof
|
|
CN110903381A
|
|
Peptide KAI11 for promoting cartilage regeneration and application thereof
|
|
CN110627866A
|
|
Polypeptide RLY4 and application thereof in promoting liver regeneration and inhibiting hepatocyte apoptosis
|
